The FDA on Wednesday updated its warning about potential increased arrhythmia risk in people with cardiac disease who are taking the seizure and mental health drug lamotrigine (Lamictal) with new data ...
LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...
Lamotrigine is a generic prescription drug. It’s FDA-approved to treat the following conditions: Lamotrigine is a generic drug. It’s also available in the following brand-name versions: Lamictal, ...
Dr. Gary J. Kennedy answers the question: 'Lamotrigine For Bipolar Disorder?' — -- Question: How is lamotrigine (Lamictal) used in the treatment of bipolar disorder? What are the side effects and ...
Learn everything you need to know about Lamotrigine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...
A growing body of data suggests that the glutamatergic system may be involved in the pathophysiology and treatment of severe mood disorders. Chronic treatment with the antimanic agents, lithium and ...
Please provide your email address to receive an email when new articles are posted on . Researchers observed differences in survival between antiseizure medications in post-stroke epilepsy, with ...
Avoid alcohol intake while using lamotrigine as it can cause some side effects like drowsiness, dizziness, difficulty concentrating and impairment in thinking (1 Trusted Source National Institute on ...
June 3, 2009 — The FDA has approved lamotrigine extended-release tablets (Lamictal XR, GlaxoSmithKline) as once-daily adjunctive therapy for partial-onset seizures with or without secondary ...
A32:01 carriage is strongly associated with risk of lamotrigine-induced DRESS, according to new research being presented at the 2026 AAAAI Annual Meeting.
The anticonvulsant medication lamotrigine can cause the rare but serious immune system reaction hemophagocytic lymphohistiocytosis (HLH), the US and Food and Drug Administration said today in a safety ...
Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The "Lamotrigine (CAS 84057-84-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results